Modulation of Cellular Response to Arsenic Trioxide Toxicity by Resveratrol

Modulation of Cellular Response to Arsenic Trioxide Toxicity by Resveratrol

Bibliographic Details
Main Authors:	Bodhisattwa Mondal, Hongxia Chen, Weihua Wen, Ercole L. Cavalieri, Eleanor G. Rogan, Muhammad Zahid
Format:	Article
Language:	English
Published:	American Chemical Society 2018-05-01
Series:	ACS Omega
Online Access:	http://dx.doi.org/10.1021/acsomega.7b01727

Similar Items

The 3,4-Quinones of Estrone and Estradiol Are the Initiators of Cancer whereas Resveratrol and <i>N</i>-acetylcysteine Are the Preventers
by: Ercole Cavalieri, et al.
Published: (2021-07-01)

Arsenic trioxide and resveratrol show synergistic anti-leukemia activity and neutralized cardiotoxicity.
by: Yuhua Fan, et al.
Published: (2014-01-01)

Resveratrol and arsenic trioxide act synergistically to kill tumor cells in vitro and in vivo.
by: Xiao-Yan Zhao, et al.
Published: (2014-01-01)

Hesperidin attenuates arsenic trioxide-induced cardiac toxicity in rats
by: Gayatri Khuntia, et al.
Published: (2023-01-01)

Evaluation of chronic toxicity of Kushta Sammulfar (calx of Arsenic trioxide)
by: Athar Parvez Ansari, et al.
Published: (2013-06-01)

Response to arsenic trioxide in dental treatment
by: Chen Gin
Published: (2013-06-01)

Arsenic Trioxide: Pharmacological Applications
by: German Madrigal Redondo, et al.
Published: (2023-04-01)

Arsenic Trioxide Modulates the Central Snail Neuron Action Potential
by: Guan-Ling Lu, et al.
Published: (2009-09-01)

Protective effects of protocatechuic acid against doxorubicin- and arsenic trioxide-induced toxicity in cardiomyocytes
by: Shafiee Fatemeh, et al.
Published: (2023-01-01)

Arsenic trioxide as an inducer of immunogenic cell death
by: Oliver Kepp, et al.
Published: (2023-12-01)

In silico mechanisms of arsenic trioxide-induced cardiotoxicity
by: Yacong Li, et al.
Published: (2022-12-01)

Arsenic Trioxide Compound Modulates Multiple Myeloma Phenotypes: Assessment on Cell Line Models
by: MR Khorramizadeh, et al.
Published: (2006-03-01)

Arsenic Trioxide Compound Modulates Multiple Myeloma Phenotypes: Assessment on Cell Line Models
by: MR Khorramizadeh, et al.
Published: (2006-05-01)

Evaluation of response to arsenic trioxide in patients with refractory multiple myeloma
by: Zohreh Sanaat, et al.
Published: (2010-03-01)

Protective Effect of α-Lipoic Acid Against Arsenic Trioxide–Induced Acute Cardiac Toxicity in Rats
by: Masafumi Kumazaki, et al.
Published: (2011-01-01)

A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
by: Kamran Alimoghaddam
Published: (2014-09-01)

Arsenic trioxide sensitizes glioblastoma to a myc inhibitor.
by: Yayoi Yoshimura, et al.
Published: (2015-01-01)

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
by: Peng Zhang
Published: (2017-01-01)

PML-RARA mutations confer varying arsenic trioxide resistance
by: Dong-Mei Bai, et al.
Published: (2016-12-01)

Treatment of new cases of Acute Promyelocytic Leukemia With Arsenic Trioxide
by: Ardeshir Ghavamzadeh, et al.
Published: (2005-03-01)

Treatment of new cases of Acute Promyelocytic Leukemia With Arsenic Trioxide
by: Ardeshir Ghavamzadeh1, et al.
Published: (2005-06-01)

Use of Arsenic Trioxide as an Antivascular and Thermosensitizing Agent in Solid Tumors
by: Robert J. Griffin, et al.
Published: (2000-01-01)

Cytotoxicity patterns of arsenic trioxide exposure on HaCaT keratinocytes
by: Udensi UK, et al.
Published: (2011-12-01)

Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
by: Sun Ramon C, et al.
Published: (2011-11-01)

Factors determining sensitivity and resistance of tumor cells to arsenic trioxide.
by: Serkan Sertel, et al.
Published: (2012-01-01)

Correction: Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor.
by: Yayoi Yoshimura, et al.
Published: (2016-01-01)

Establishment and characterization of arsenic trioxide resistant KB/ATO cells
by: Yun-Kai Zhang, et al.
Published: (2017-09-01)

Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
by: Li Ning, et al.
Published: (2012-10-01)

Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal
by: Degang Kong, et al.
Published: (2020-01-01)

Heme Oxygenase-1 Inhibition Modulates Autophagy and Augments Arsenic Trioxide Cytotoxicity in Pancreatic Cancer Cells
by: Iman M. Ahmad, et al.
Published: (2023-09-01)

Arsenic album 30C exhibits crystalline nano structure of arsenic trioxide and modulates innate immune markers in murine macrophage cell lines
by: Suvasmita Rath, et al.
Published: (2024-01-01)

Arsenic toxicity: the effects on plant metabolism
by: Patrick eFinnegan, et al.
Published: (2012-06-01)

Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
by: Yu Zheng, et al.
Published: (2021-02-01)

Arsenic trioxide-induced cardiotoxicity: the protective effect of 2-aminoethoxydiphenyl-borate
by: Feng Jia, et al.
Published: (2024-03-01)

Current Advances of Nanomedicines Delivering Arsenic Trioxide for Enhanced Tumor Therapy
by: Mengzhen Yu, et al.
Published: (2022-03-01)

Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
by: Jiabing Li, et al.
Published: (2023-11-01)

Vorinostat enhances chemosensitivity to arsenic trioxide in K562 cell line
by: Nainong Li, et al.
Published: (2015-05-01)

Lenalidomide in Combination with Arsenic Trioxide: an Effective Therapy for Primary Effusion Lymphoma
by: Sara Moodad, et al.
Published: (2020-09-01)

Arsenic trioxide for acute promyelocytic leukemia in a patient on chronic hemodialysis
by: Jose Tinajero, et al.
Published: (2022-01-01)

Honokiol attenuate the arsenic trioxide‐induced cardiotoxicity by reducing the myocardial apoptosis
by: An‐Liang Huang, et al.
Published: (2022-04-01)